Organization
Jan van Breemen Research Institute, Reade, Netherlands
4 abstracts
Abstract
14-3-3 ETA IS AN EARLY RA BIOMARKER THAT IS MODIFIABLE WITH STANDARD DMARDS AND CORRESPONDS WITH IMPROVEMENT IN CLINICAL VARIABLES Org: Jan van Breemen Research Institute, Reade, Netherlands, Univeristy of Alberta, Edmonton, Augurex Life Sciences Corp, North Vancouver, Canada,
Abstract
14-3-3 ETA MARKS RADIOGRAPHIC PROGRESSION IN AN EARLY ARTHRITIS COHORT Org: Jan van Breemen Research Institute, Reade, Netherlands, Augurex Life Sciences Corp, North Vancouver, Canada, University of Alberta, Edmonton, Canada,
Abstract
ADALIMUMAB SIGNIFICANTLY REDUCES RECURRENCE RATE OF ANTERIOR UVEITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS Org: Jan van Breemen Research Institute, Reade, Netherlands, Rheumatology, VU University Medical Center, Ophtalmology, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands,
Abstract
ASSOCIATIONS BETWEEN PROPRIOCEPTION, LAXITY, MUSCLE STRENGTH AND ACTIVITY LIMITATIONS IN EARLY SYMPTOMATIC KNEE OSTEOARTHRITIS: RESULTS FROM THE CHECK COHORT Org: Amsterdam Rehabilitation Research Centre, Reade, EMGO Institute for Health and Care Research, Rehabilitation Medicine, VU University Medical Centre, Jan van Breemen Research Institute, Reade, Netherlands, Rheumatology, VU University Medical Centre, Amsterdam, Netherlands,